News & Events

Underweight women and patients with low baseline lymphocyte counts should be monitored more closely

A new way to predict the transition from relapsing-remitting to secondary-progressive MS

Computer-aided cognitive rehabilitation can slow down cognitive impairment in MS patients

French study supports the idea of avoiding delays after pregnancy before starting natalizumab therapy

Fampridine must be used with caution in people with a history of MS-related trigeminal neuralgia

Researchers find that Alfacalcidol is a safe and effective treatment for fatigue

The register aims to address the recognised lack of relevant MS data at European level

The UK MS Society’s campaign calls for the right treatment at the right time

Volunteers from MS organisations in Lebanon, Egypt and Jordan took part in a three-day training course

This year’s McDonald Fellowships went to researchers from Bangladesh, Hungary, Iran and Yemen

The second wave of 2014 grants includes scientists from Iran, Italy, Romania and Russia

Pegylated interferon lasts longer, so needs to be taken less often, with fewer side effects